- NBFC woes, rising rates send India Inc CFOs' optimism to 19-qtr low: Poll
- Tata Steel Q2 consolidated net profit at Rs 31.16 bn, up three folds YoY
- CNN sues Trump White House for revoking Jim Acosta's press credentials
- Navy establishing high-tech control room to monitor Indian Ocean sea lanes
- Binny Bansal, Flipkart's 'execution man', who delivered and kept low
N G Industries Ltd.
|BSE: 530897||Sector: Health care|
|NSE: N.A.||ISIN Code: INE825C01018|
|BSE 00:00 | 13 Nov||65.40||
|NSE 05:30 | 01 Jan||N G Industries Ltd|
N G Industries Ltd. (NGINDS) - News Sector
8.02 pm | 13 Nov 2018 | Business Standard
Company misses revenue estimates too, delivering a top line of Rs 69.37 bn, up a moderate 4.3%. Analysts had expected double-digit revenue growth for ...
5.47 pm | 13 Nov 2018 | Press Trust of India
The board of Fortis has also approved the appointment of four IHH nominees on the company's board
5.39 pm | 13 Nov 2018 | Business Standard
The senior management of Aurobindo said they are looking at launching the Oncology products in the US market by the end of this year
11.14 am | 13 Nov 2018 | Business Standard
The company reported a 21.7 per cent decline in net profit at Rs 6.11 billion for the quarter ended September 2018, owing to rise in costs.
8.53 am | 13 Nov 2018 | Business Standard
Here's a look at the top stocks that may remain in focus in today's trade -
9.12 pm | 12 Nov 2018 | Business Standard
The company was able to improve its US formulations revenues by 6.1 per cent year-on-year at Rs 22.27 billion.
1.51 am | 12 Nov 2018 | Business Standard
The Fortis stock has seen an erosion of 5.4% since the deal was announced in mid-July
10.39 pm | 10 Nov 2018 | Business Standard
Vinay Kumar, a chronic diabetic living on the insulin pump, is helping early detection and complete management of diabetes through his novel invention...
4.59 pm | 9 Nov 2018 | Business Standard
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period
11.30 pm | 8 Nov 2018 | Business Standard
Sources indicated the resignation comes in at a time when the management control of the firm is changing and the new promoters are unlikely to have 'l...
8.53 pm | 8 Nov 2018 | Reuters
It is the first quarter of sustainable product sales growth since 2014 and shares in the group, which staved off a takeover bid from Pfizer four years...
7.16 pm | 8 Nov 2018 | Business Standard
Domestic market has contributed a third of Natco Pharma's revenues of Rs 22 billion in 2017-18, though slipped in sales for the first time
6.11 pm | 8 Nov 2018 | Press Trust of India
Singh has steered the organisation over the past three and a half years
1.42 pm | 8 Nov 2018 | Business Standard
Insulin Glargine is the first biosimilar from India to be approved and launched in Japan
12.04 am | 7 Nov 2018 | Press Trust of India
Operating margin declined to 28.5 per cent as against 29 per cent a year ago
12.00 am | 7 Nov 2018 | Press Trust of India
At NSE, shares of the company dropped 5.87% to close at Rs 529.95
10.59 am | 6 Nov 2018 | Business Standard
The stock was down 5% at Rs 534, trading at its lowest level since June 6, 2018 on the BSE.
12.45 am | 6 Nov 2018 | Business Standard
Company cautious on prospects, given supply disruptions & commodity inflation, among others
12.17 am | 6 Nov 2018 | Business Standard
The company noted in a statement that the net profit for Q2FY19 was primarily impacted by impairment of goodwill and investments
9.44 pm | 5 Nov 2018 | Business Standard
Tender business, which accounts for around 20% of consolidated sales, came under pressure because of intense competition and aggressive pricing